MARKET EYE-Cipla gains on partner's contract win

Fri Nov 30, 2012 10:45am IST

Related Topics

Stocks

   

* Shares in drugmaker Cipla rise 1.4 percent after
Cipla Medpro won a share in South Africa's $667 million
contract, as it supplies the bulk of Cipla Medpro's drugs.
* Dealers say the company may garner revenues of $30-40 million
from Cipla Medpro's contract.
* South Africa on Thursday awarded a $667 million contract to
supply life-prolonging HIV medicine to 12 international and
domestic firms, including Cipla Medpro, to deal with its biggest
health problem. 
* Cipla also plans to offer $215 million for a majority stake in
South Africa's Cipla Medpro to strengthen its presence in
Africa's fast-growing market for cheap, generic versions of
branded drugs. 

 (abhishek.vishnoi@thomsonreuters.com /;
abhishek.vishnoi.reuters.com@reuters.net)
FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.

  • Most Popular
  • Most Shared

Economic Pulse

REUTERS SHOWCASE

Political Pulse

Political Pulse

100 days of Modi: Good for business, not so good for marginalised groups.  Full Article 

Segway in India

Segway in India

Segway’s India business pegs hope on tech-savvy Modi  Full Article 

Best Economy

Best Economy

Swiss economy most competitive once again; EU, U.S., Japan improve.  Full Article 

Power Outage

Power Outage

Mumbai hit by power cuts  Full Article 

Commodities

Commodities

Gold imports, premiums to jump on festive demand - top refiner  Full Article 

Economic Worries

Economic Worries

Pakistan's promises to IMF in doubt as protests sap economy   Full Article 

Islamic Finance

Islamic Finance

Basel III deposit challenge looms over Islamic banks   Full Article 

Antitrust Probes

Antitrust Probes

U.S. business lobby says concerned China antitrust probes unfair.  Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device.  Full Coverage